Journal Article:
Summary:
Daniel DeMarco Journal Article Assignment Rotation #5: Peds
Eosinophilic Esophagitis
Glenn T. Furuta, MD and David A Katzka MD
New England Journal of Medicine
What is it?:
- “Chronic, immune-mediated or antigen-mediated esophageal disease characterized by symptoms related to esophageal dysfunction and eosinophil-predominant inflammation”
- Predominant antigens = food-based antigens
Epidemiology?:
- Western World prevalence estimate = 0.4% of all children and adults
- Increasing prevalence in Asia
- Male predominance: 3:1; predominantly white men with onset from school age to midlife
- Factors associated with increased risk of eosinophilic esophagitis (EOE): birth by C-section, prematurity, antibiotic exposure during infancy, food allergy, lack of breast-feeding, living in areas of lower population density, personal or family history of atopic disorders: asthma, eczema, rhinitis, anaphylactic food allergy
- Genetic Component = family history of EOE, three genes altered in EOE based on genome studies
- Co-existing conditions = connective-tissue disease, celiac disease, Crohn’s disease
Symptoms?:
- In Children?: feeding problems, failure to thrive, vomiting, nausea, heartburn, abdominal pain
- In Adolescents and Adults?: dysphagia, food impaction
- In All?: chronic reflux symptoms
DDx?:
- GERD
- Parasitic infection
- Allergic vasculitis
- Esophageal leomyomatosis
- Crohn’s disease
Pathogenesis?:
- Combination of:
- Impaired Barrier Function: dilated interepithelial spaces, altered epithelial barrier function, down-regulation of proteins with barrier function which alter the epithelial permeability = increased antigen presentation = increased recruitment of eosinophils
- Enhanced TH2 Activity and Allergic Susceptibility
- IL-5 and IL-13: treatment with anti-IL5 and IL-13 antibodies decreases esophageal eosinophils in children and adults
- Food-specific IgG4
Procedures/Imaging?:
- Upper Endoscopy + Biopsy
- Intraluminal Balloon Device to measure wall compliance
- Contrast Esophagography
Endoscopic Findings?:
- “White Specks” = eosinophilic exudates
- Mucosal edema
- Linear furrows
- Esophageal rings
- Strictures
- “Crepe-Paper Esophagus” = linear tears 2’ to trauma
- “Tug Sign” = firm feeling felt by endoscopist
- Development of validated endoscopic scoring system = EREFS
- Edema
- Rings
- Exudates
- Furrows
- Strictures
Barium Esophagography?:
- Strictures/narrowing may not be detected on endoscopy = often there is evidence of this on barium esophagography
Findings on Histology?:
- Hallmark = Esophageal mucosa with > or = to 15 eosinophils per high-power field
- Sensitivity = 100%
- Specificity = 96%
- Other:
- Aggregates of eosinophils = microabscess
- Eosinophil layers along luminal surface
- Dilated intercellular spaces
- Rete-peg elongation
- Basal-cell hyperplasia
- Increased number of other inflammatory cells = lymphocytes, mast cells, basophils
Complications:
- Esophageal stricture
- Food impaction
- Perforation
- Malnutrition
- EOE IS NOT PRE-MALIGNANT
Treatment:
- Goals = alleviate symptoms, control inflammation, restore function
- Modalities = diet, drugs, dilation
- Team = gastroenterologist, allergist, nutritionist
- Diet
- Amino-acid based formula (elemental diet)
- Allergen-targeted diets
- Six-food elimination: wheat, milk, soy, nuts, eggs, seafood
- Challenges: inc. cost of food, poor adherence, nutritional deficiencies
- Drugs
- Proton Pump Inhibitors = decrease cytokine secretion from esophageal epithelium possibly conferring anti-inflammatory effect
- “Proton-pump inhibitor-responsive EOE”
- Topical Glucocorticoids = decrease inflammatory cells, decrease fibrosis, reversal of IL-13 and EOE transcriptome
- Fluticasone orally (MDI)
- Budesonide orally (Viscous Liquid)
- S/E: local candida infection, adrenal axis suppression, bone demineralization, diminished growth
- Proton Pump Inhibitors = decrease cytokine secretion from esophageal epithelium possibly conferring anti-inflammatory effect
- Dilation
- Alleviation of esophageal narrowing
- No effect on inflammatory process